Description of the neuropsychological data of the CCC and ADNI sample (M ± SD: mean ± standard deviation and %MV: percentage or missing values are reported). (DOCX 45 kb
Table S1. Distribution of Erlangen Score neurochemical categories (0–4) across the four diagnostic g...
Replication of the methodology proposed in previous works [28, 29] with the data(CCC) used in our st...
Neuropsychological assessments, raw scores I & II. Data displayed as raw scores for each patient on ...
Individual and pairwise stability of the base FS algorithms used in the ensemble, using CCC data. (D...
Stability and classification performance of classification models learnt with an incremental number ...
Figure S1. Receiver operating characteristics (ROC) curves for (A) distinguishing between AD-dementi...
Items of ADAS-Cog variants. Supplementary table providing details about items of ADAS-Cog variants. ...
Table S1. Sensitivity and specificity of neuropathology prediction models. Table S2. Neuropathology ...
Voxel-based morphometric analysis of global atrophy in the dementia with Lewy bodies group or the Al...
STROBE Statement—Checklist of items that should be included in reports of cohort studies. (PDF 28 kb
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivit...
Results of multiple linear regression models without control for confounding variables. Values are β...
Figure S1. Grey matter volume reduction in the Alzheimer’s disease group (n = 39) compared to health...
Showing partial correlations between the normalized behavioural scores and the normalized volumes of...
Table S1. Demographic, clinical and genetic data of the MCI subgroups based on a CSF biomarker profi...
Table S1. Distribution of Erlangen Score neurochemical categories (0–4) across the four diagnostic g...
Replication of the methodology proposed in previous works [28, 29] with the data(CCC) used in our st...
Neuropsychological assessments, raw scores I & II. Data displayed as raw scores for each patient on ...
Individual and pairwise stability of the base FS algorithms used in the ensemble, using CCC data. (D...
Stability and classification performance of classification models learnt with an incremental number ...
Figure S1. Receiver operating characteristics (ROC) curves for (A) distinguishing between AD-dementi...
Items of ADAS-Cog variants. Supplementary table providing details about items of ADAS-Cog variants. ...
Table S1. Sensitivity and specificity of neuropathology prediction models. Table S2. Neuropathology ...
Voxel-based morphometric analysis of global atrophy in the dementia with Lewy bodies group or the Al...
STROBE Statement—Checklist of items that should be included in reports of cohort studies. (PDF 28 kb
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivit...
Results of multiple linear regression models without control for confounding variables. Values are β...
Figure S1. Grey matter volume reduction in the Alzheimer’s disease group (n = 39) compared to health...
Showing partial correlations between the normalized behavioural scores and the normalized volumes of...
Table S1. Demographic, clinical and genetic data of the MCI subgroups based on a CSF biomarker profi...
Table S1. Distribution of Erlangen Score neurochemical categories (0–4) across the four diagnostic g...
Replication of the methodology proposed in previous works [28, 29] with the data(CCC) used in our st...
Neuropsychological assessments, raw scores I & II. Data displayed as raw scores for each patient on ...